Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Hemorrhage 5Hematologic Neoplasms 3Head and Neck Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Osteosarcoma 1Myofibroma 1Metrorrhagia 1Meningioma 1Melanoma 1Leiomyoma 1Glioma 1Breast Neoplasms 1Astrocytoma 1

Interventions

vapreotide 1Wound Closure Techniques 1World Health Organization oral rehydration solution 1Tranexamic Acid 1Tracheostomy 1Therapeutics 1Surgical Procedures, Operative 1Sodium Chloride 1Ropivacaine 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Neoadjuvant Therapy 1Intermittent Pneumatic Compression Devices 1Fondaparinux 1Fluorouracil 1Fibrin Tissue Adhesive 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Postoperative Complications × Tranexamic Acid × Clear all
NCT01651182 2015-09-18

Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection

Sunnybrook Health Sciences Centre

Phase 3 Completed
24 enrolled

Hemorrhage, Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡